Global X Genomics & Biotechnology ETF Rating $8.30 -0.13 (-1.54%) Closing price 06/13/2025 03:59 PM EasternExtended Trading$8.32 +0.01 (+0.18%) As of 06/13/2025 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Global X Genomics & Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GNOM Aggregate RatingModerate Buy 2.69Holdings in GNOM have an aggregate rating of Moderate Buy based on 624 analyst ratings issued in the past year covering 47 companies (95.5% of the portfolio).GNOM Aggregate Price Target$8.30High Prediction$8.30Average Prediction$8.30Low Prediction$8.30Holdings in GNOM have an aggregate price target of $8.30 and a range of $8.30 to $8.30 covering 47 companies (95.5% of the portfolio).GNOM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy29 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Genomics & Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 47 GNOM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.21%ALNYAlnylam Pharmaceuticals$307.99+1.1%4.2479 of 5 stars2.77$319.58 3.8%26Analyst Forecast4.48%ILMNIllumina$86.93-1.4%4.8769 of 5 stars2.47$126.94 46.0%19Positive NewsAnalyst ForecastOptions Volume4.38%NTRANatera$165.34+0.6%1.8723 of 5 stars3.00$184.63 11.7%15Positive NewsInsider Trade4.31%QGENQiagen$47.08-0.7%3.336 of 5 stars2.30$48.42 2.8%104.30%RNAAvidity Biosciences$31.37-2.4%2.0841 of 5 stars3.07$67.33 114.6%15Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionGap Down4.19%MRNAModerna$26.67-2.5%4.4417 of 5 stars2.04$46.61 74.8%23Trending NewsOptions VolumeGap Down4.13%CRSPCRISPR Therapeutics$41.36+0.2%3.2892 of 5 stars2.50$71.75 73.5%18Analyst RevisionGap Down4.09%RAREUltragenyx Pharmaceutical$37.49-4.6%4.4084 of 5 stars2.92$88.77 136.8%13Analyst Revision4.07%BMRNBioMarin Pharmaceutical$56.22-1.9%4.9395 of 5 stars2.74$93.45 66.2%23Positive NewsAnalyst Revision4.01%TECHBio-Techne$50.52-2.0%4.8502 of 5 stars2.45$72.00 42.5%11Gap Down3.81%VRTXVertex Pharmaceuticals$455.45-1.0%4.6311 of 5 stars2.57$515.04 13.1%30Positive NewsAnalyst Revision3.72%BNTXBioNTech$106.57+1.6%2.8263 of 5 stars2.83$138.25 29.7%18Trending News3.56%LEGNLegend Biotech$36.83-2.8%3.0653 of 5 stars2.91$76.20 106.9%11Short Interest ↑Analyst RevisionGap Up3.50%GHGuardant Health$49.29+0.6%3.734 of 5 stars3.00$53.76 9.1%21Analyst ForecastGap Down3.00%VCYTVeracyte$26.44-0.9%4.0651 of 5 stars2.70$40.90 54.7%10Positive NewsAnalyst Upgrade2.90%SRPTSarepta Therapeutics$36.18-3.0%4.7083 of 5 stars2.87$122.61 238.9%232.46%ARWRArrowhead Pharmaceuticals$15.74-3.0%3.5995 of 5 stars2.75$43.71 177.7%8Analyst UpgradeAnalyst Revision2.37%WGSGeneDx$64.57-2.7%3.6816 of 5 stars2.75$86.75 34.4%8News CoverageGap Down2.26%TWSTTwist Bioscience$33.52-0.3%4.1064 of 5 stars2.70$50.40 50.4%10Gap Down2.23%AAgilent Technologies$116.97-1.6%4.5945 of 5 stars2.50$140.15 19.8%14Analyst Downgrade2.17%GILDGilead Sciences$109.98-1.8%4.853 of 5 stars2.78$110.55 0.5%27Trending NewsOptions VolumeAnalyst Revision2.08%BEAMBeam Therapeutics$17.06-2.2%3.2325 of 5 stars3.00$48.75 185.8%15Analyst RevisionGap Down2.08%BMYBristol-Myers Squibb$49.71-1.9%4.8409 of 5 stars2.32$58.00 16.7%22Analyst Revision1.88%LLYEli Lilly and Company$818.56+0.8%4.8034 of 5 stars2.76$1,011.37 23.6%21Trending NewsAnalyst Revision1.26%NTLAIntellia Therapeutics$8.31-0.5%4.5921 of 5 stars2.67$34.95 320.6%21Analyst RevisionGap Down1.24%CDNACareDx$18.59-1.3%3.7225 of 5 stars2.67$30.33 63.2%6Insider TradeGap Down1.19%TXG10x Genomics$10.41-1.6%4.2072 of 5 stars2.38$15.81 51.9%16Analyst ForecastGap Down1.08%QUREuniQure$15.34-4.1%2.0714 of 5 stars2.91$37.82 146.5%11Analyst DowngradeAnalyst Revision1.04%WVEWave Life Sciences$6.95-3.5%4.2505 of 5 stars2.92$20.50 195.0%12News CoveragePositive NewsAnalyst ForecastInsider TradeAnalyst Revision1.00%PRAXPraxis Precision Medicines$44.30-1.6%2.577 of 5 stars2.80$109.90 148.1%10Analyst ForecastGap Down0.92%RCKTRocket Pharmaceuticals$2.93-4.6%4.951 of 5 stars2.41$19.57 568.0%17Trending NewsAnalyst RevisionGap Down0.61%RGNXREGENXBIO$9.27-9.1%4.2794 of 5 stars2.83$31.63 241.2%6Gap Down0.57%FLGTFulgent Genetics$20.69-1.4%3.851 of 5 stars2.50$24.00 16.0%2Gap Down0.56%VIRVir Biotechnology$5.222.9937 of 5 stars2.86$32.86 529.4%7Positive NewsGap Down0.55%STOKStoke Therapeutics$11.53-2.5%3.61 of 5 stars3.29$23.20 101.2%7Analyst RevisionGap Down0.51%CVACCureVac$5.57-0.5%4.2766 of 5 stars2.67$9.00 61.6%3Trending NewsAnalyst ForecastOptions VolumeGap DownHigh Trading Volume0.50%MYGNMyriad Genetics$5.03-3.1%4.2247 of 5 stars2.13$14.38 186.0%160.42%ARCTArcturus Therapeutics$12.38-2.1%3.2102 of 5 stars3.11$53.50 332.1%9Analyst RevisionGap Up0.41%PSNLPersonalis$6.01+3.4%4.3875 of 5 stars3.00$7.67 27.6%60.39%VERVVerve Therapeutics$6.16-2.5%2.2835 of 5 stars3.00$25.75 318.0%6Gap Down0.37%SANASana Biotechnology$2.59+2.0%1.9378 of 5 stars2.86$10.80 317.0%70.37%MRVIMaravai LifeSciences$2.13-5.8%4.0092 of 5 stars2.25$6.64 211.7%12Options VolumeGap Down0.36%PACBPacific Biosciences of California$1.20+1.7%2.0545 of 5 stars2.50$2.13 77.6%8Positive News0.29%CRGXCARGO Therapeutics$4.39-2.0%2.3804 of 5 stars1.86$15.00 241.7%7Positive News0.22%ALLOAllogene Therapeutics$1.34-4.3%3.8435 of 5 stars2.90$8.44 530.2%10Positive NewsGap Down0.21%PRMEPrime Medicine$1.463.8925 of 5 stars2.75$10.08 590.6%8Positive News0.21%SGMOSangamo Therapeutics$0.49-2.4%2.0275 of 5 stars2.67$4.50 816.5%6Positive NewsGap Down This page (NASDAQ:GNOM) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GNOM Stock Free GNOM Stock Alerts